Upgrade to SI Premium - Free Trial

Geron Corp (GERN), Janssen Pharma Enter Exclusive Licensing Agreement

September 19, 2016 8:08 AM
Geron Corp (Nasdaq: GERN) disclosed the following in a U.S. SEC filing on Monday:Item 1.01 Entry into a Material Definitive ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation

Next Articles